BostonGene
Tumor Portrait sequences your tumor's DNA and RNA and compares it with your normal DNA from saliva, a cheek swab or blood. Your doctor orders it. In October 2026 my cost was $4,500 out of pocket.
Testing & profiling
Back to Treatment & Testing13 organizations
Company
Caris Life Sciences
Caris tests tumor tissue or blood, reading the whole exome and transcriptome to look for changes that point to targeted drugs, immunotherapy or trials. Your oncologist orders it.
Foundation Medicine
Foundation Medicine tests tumor tissue or blood for gene changes that can point to targeted drugs, immunotherapy or clinical trials. Your doctor orders it, and the report goes to your care team.
Guardant Health
Blood and tissue tests to find tumor biomarkers. Separate tests track residual disease and treatment response.
Inocras
CancerVision compares tumor and normal DNA using whole-genome sequencing, with report support and trial matching.
Academic / research center
Johns Hopkins Pathology
A second reading of pathology material, rather than a consultation about the entire cancer treatment plan.
Natera (Signatera)
Natera's Signatera is a personalized blood test, built from your tumor, that looks for traces of tumor DNA to check for remaining cancer, track treatment and catch a recurrence earlier. Your doctor orders it.
Palitra
Tests treatment options on tumor cells to help explore drug combinations.
Selvana
Develops blood-based tracking of a cancer’s presence, amount and changes over time.
Sophont
Holon-S1 uses AI to infer spatial gene-expression patterns from digitized pathology slides. Research only.
In research
Tempus
Tempus runs genomic tests on tumor tissue, blood and saliva to help guide treatment, check for inherited risk and monitor for remaining cancer. Your doctor orders the test.
Travera
Tests drugs on live tumor cells outside the body and returns a report to the ordering physician.
Valius Sciences
Deep tumor profiling across DNA, RNA and proteins, using existing fixed tissue.
